Purpose Care | AI Transformation Index

PurposeCare operates in a structurally durable segment of healthcare — physical, licensed, regulated, and physically irreplaceable — which makes it one of ...

Purpose CareHealthcare (Medical - Care Facilities)Lorient Capital

Overview

PurposeCare delivers skilled home health and home/community-based services (nursing, therapy, personal care, care coordination) to geriatric and dual-eligible Medicare/Medicaid populations across the Midwest, generating revenue by billing government and commercial payors under fee-for-service and value-based arrangements.

Executive Summary

PurposeCare operates in a structurally durable segment of healthcare — physical, licensed, regulated, and physically irreplaceable — which makes it one of the more AI-resilient service business models in a PE portfolio. The AI opportunity, while bounded by the physical nature of care delivery, is concentrated in exactly the right places: clinical workflow compression, deterioration prediction across complex patient populations, and the enabling of value-based contracts that could structurally reprice the business. The strategic thesis is that AI makes PurposeCare a better, more defensible operator (lower documentation burden, better outcomes, VBC eligibility) without threatening the core revenue base — a favorable combination that justifies continued investment in clinical intelligence infrastructure like Canarai as a competitive differentiator rather than a mere efficiency tool.

Durability

How resilient is this business against AI disruption?

FactorValue

Market Substitutability

10

Profit Pool Migration

8

Barrier to Entry

10

Disintermediation Exposure

8

Switching Costs

5
Total82.0
×

Opportunity

How big a deal is AI for this business?

FactorValue

AI Applicability

5

Improvement Magnitude

8

Transformation Upside

5

Domain Intelligence Amplification

7
Total62.5

71.6

Ciridae AI Score

Durability Rationale

PurposeCare's durability rests on a structurally sound foundation: the paid outcome is physical clinical care that no AI can replicate, the market is heavily regulated and licensed in ways that create durable entry barriers, and the company owns both the payor contracts and the clinical workforce rather than sitting as a middleman between them. The primary durability risk is not AI substitution of the core service but rather competitive commoditization at the organizational level — at its current scale, PurposeCare has not yet built the switching costs and brand differentiation needed to fend off better-capitalized nationals or tech-enabled platforms that could out-invest it on the AI coordination layer. Regulatory moat and physical delivery irreplaceability are the structural anchors; organizational scale and moat depth are the vulnerability.

Opportunity Rationale

The AI opportunity for PurposeCare is real and concentrated in the workflows surrounding physical care delivery — clinical documentation, deterioration detection, scheduling, and billing — where the magnitude of improvement is genuinely large and the domain intelligence (complex geriatric/dual-eligible patient populations, unstructured clinical data) is rich enough to amplify. The Canarai initiative signals the company already understands where the leverage is. The bigger strategic upside is that AI-enabled risk stratification unlocks value-based contracting at scale — transforming PurposeCare from a fee-for-service visit business into a population health manager that gets paid for outcomes, a fundamentally different and more defensible economic position. The opportunity is bounded by the fact that the majority of revenue hours remain physical and AI-irreducible, so this is not a story of total cost structure transformation, but the addressable AI upside is high-value and strategically differentiated.

Key Risks

The durability view could be wrong if hospital-at-home platforms (backed by major health systems or payers) absorb the complex-patient population and leave PurposeCare with lower-acuity, commoditized non-medical home care — reducing payor contract leverage and intensifying price competition without the clinical differentiation that justifies the roll-up premium.

The opportunity view could be wrong if the Canarai platform and AI clinical intelligence tools remain a feature available to any operator through third-party vendors (e.g., Google Health, Medalogix, Forcura), meaning PurposeCare cannot sustain a differentiated advantage from AI investment and competitors rapidly close any capability gap.

Company Overview

HeadquartersJeffersonville, IN (corporate office reported)
Products / Services
Skilled nursing, physical/occupational/speech therapy, medical social services, wound and ostomy management, IV/infusion therapy, personal/home care (bathing, ADL assistance, medication reminders, transportation, light housekeeping), comprehensive care coordination and home safety assessments.

AI & Tech Initiatives

NameDescription
CanaraiProprietary data platform that ingests 40+ disparate sources (EHRs, clinical notes, caregiver reports, HIEs) and uses generative AI / large language models to analyze unstructured clinical text, surface subtle deterioration signals, provide risk stratification, real-time alerts, and workflow automation to support proactive home health interventions.

PE / Ownership History

EventDetails
Acquired Freedom Home Care
March 17, 2026
Acquisition of Freedom Home Care (Chicagoland / Northern Illinois) to expand PurposeCare's Midwest footprint and concierge home care offerings. No Lorient Capital Partner/Managing Partner named in the public press release.
Acquired New Era Support Services (reported)
July 2025
Reported acquisition of New Era Support Services (listed in private deal databases). Jordan Broome is the only Lorient individual explicitly named across public materials as associated with PurposeCare transactions.
Acquired additional Midwestern agencies / equity interests
January 2024
Acquisition/roll-up of three additional Midwestern home-based care agencies (including equity interests in Michiana Home Care and Queen City Skilled Care). No Lorient Capital Partner/Managing Partner named in public announcements.
Acquired three Midwest home care agencies
July 2023
Acquisition of three Midwest home care agencies (Scott’s Home Healthcare, Attentive Personal Care, The Choice Nursing Care & Home Health) expanding Indiana and Ohio presence. No Lorient Capital Partner/Managing Partner named in public announcements.
Acquired Home Sweet Home In-Home Care
March 21, 2023
Acquisition of Home Sweet Home In-Home Care (St. Joseph, MI) — expanded Midwest footprint (~400 patients, ~300 caregivers reported for the acquired agency). No Lorient Capital Partner/Managing Partner named in public announcement.
Initial investment / formation (Lorient Capital-backed)
December 2021
Lorient Capital provided the institutional backing to form PurposeCare and support an initial acquisition strategy to consolidate regional home health and home care agencies.

Executives

NameBackground
Richard (Rich) Keller
Chief Executive Officer (CEO)
Former President and VP of Business Development & Strategy at All Metro Health Care; healthcare operator with previous consulting experience; MBA in Marketing.
Michael Eperesi
Chief Financial Officer (CFO)
Former CFO at Guardian Healthcare and advisory roles; background in financial leadership in healthcare and information systems management.
Rob Barrow
Chief Operating Officer (COO)
Joined PurposeCare as COO in 2023; prior operational roles at Lorient Capital portfolio companies and experience running home health/home care operations and operational performance programs.